Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer.
Journal: JNCI cancer spectrum
Published: October 20, 2025
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma.
Journal: Oncoimmunology
Published: October 15, 2021
Phase II clinical trial using anti-CD3 × anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) consolidation therapy for HER2 negative (0-2+) metastatic breast cancer.
Journal: Journal for immunotherapy of cancer
Published: May 08, 2021
Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis.
Journal: Journal for immunotherapy of cancer
Published: March 27, 2021
Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 28, 2019
Cancer Site and Adverse Events Induced by Immune Checkpoint Inhibitors: A Retrospective Analysis of Real-life Experience at a Single Institution.
Journal: Anticancer research
Published: October 29, 2018
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma.
Journal: Journal for immunotherapy of cancer
Published: January 25, 2018
High frequency of brain metastases after adjuvant therapy for high-risk melanoma.
Journal: Cancer medicine
Published: June 17, 2017
Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 31, 2017
SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 26, 2014
Last Updated: 09/26/2026